Latest Breaking News On - Demonstrated strong operational - Page 1 : comparemela.com

Revenue Increased by 63.5% Y-o-Y to RMB7,206.4 Million Gross Profit Increased by 48.6% Y-o-Y to RMB3,413.2 Million Net Profit Grew by 39.2% Y-o-Y to RMB2,621.2.

Nordrhein westfalenUnited statesNew jerseyEvusheld tixagevimabChris chenUs bureau of industryShareholders of the companyManufacturing organizationWuxi biologics cayman incGroup global dualChina ministry of commerceContract researchDrug product services generate new growthUs department of commerce unverified listWuxi biologics co ltdCompany for the reporting period